Monthly Archives: October 2023

Cancer and neoplasms

Multi-system diseases and death trajectory of metabolic dysfunction-associated fatty liver disease: findings from the UK Biobank

Posted on by yun
20
Oct

The present study provides a panoramic view of temporal disease and death trajectories of MAFLD in the community-dwelling population of the UK Biobank cohort study. MAFLD was proved to be related to 113 medical conditions and eight causes of death when limiting disease incidence to ≥ 1%. The network of these diseases originates from asthma, diabetes, hypothyroid […]

Continue reading →
Blood

Donate to the Blood Harvest—Earn In-Game Rewards

Posted on by yun
20
Oct

Fresh out the shadows, the emissaries of the vampire master Lord Zir have sunk their fangs into Sanctuary’s denizens to fuel sinister rituals—called Blood Harvests—during Season of Blood. We have launched a real-life Blood Harvest, offering fans in-game rewards in exchange for donating their blood. From October 20–November 20, players in the United States over […]

Continue reading →
Congenital disorders

North America Gene Therapy Market Size, Share, Trends, Development Strategies, Competitive Scenario

Posted on by yun
20
Oct

The importance of such North America Gene Therapy Market research report is that tools of marketing campaigns (questionnaires, meetings, discussions, messaging) can be used to reach a wide audience of customers, reduce the timeframe within which product/service reaches the customers, investigate current and future needs and expectations of the customers, and achieve higher customer satisfaction. […]

Continue reading →
Infection

Decolonization Strategies to Prevent Staphylococcal Infections

Posted on by yun
20
Oct

Staphylococcal infections among hospitalized patients, due to both methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-sensitive Staphylococcus aureus strains, are a substantial problem in the US. S aureus was the leading causative pathogen among health care–associated infections (HAIs) identified during the Centers for Disease Control and Prevention’s (CDC) 2015 national HAI prevalence survey (excluding Clostridioides difficile), accounting […]

Continue reading →
Congenital disorders

Hypofibrinogenemia is an independent predictor of hemophagocytic lymphohistiocytosis in children with sepsis

Posted on by yun
20
Oct

Abstract Hemophagocytic lymphohistiocytosis (HLH) is a potentially life-threatening condition in children with sepsis. We herein aimed to identify clinical and laboratory predictors of HLH in children with sepsis. We conducted a retrospective study of 568 children with sepsis admitted to Guangdong Women and Children Hospital from January 2019 to June 2022. HLH, while rare (6.34%), […]

Continue reading →
Cancer and neoplasms

Long-term outcomes of endoscopic resection for duodenal neuroendocrine tumors

Posted on by yun
20
Oct

Abstract Duodenal neuroendocrine tumors (d-NETs) ≤ 10 mm in size, confined to the submucosal layer, without lymph node or distant metastasis, can be treated safely and effectively by endoscopic management. However, most results are based on limited data and short follow-up outcomes. Herein, we aimed to evaluate the short-term and long-term outcomes of endoscopic resection for d-NETs. We […]

Continue reading →
Cardiovascular

Sex-stratified patterns of emergency cardiovascular admissions prior and during the COVID-19 pandemic

Posted on by yun
20
Oct

Abstract The COVID-19 pandemic has had a significant impact on global public health, with long-term consequences that are still largely unknown. This study aimed to assess the data regarding acute cardiovascular hospital admissions in five European centers before and during the pandemic. A multicenter, multinational observational registry was created, comparing admissions to the emergency departments […]

Continue reading →
Blood

Global $40+ Billion Artificial Blood and Plasma Markets to 2027 Featuring Major Players, Hemarina, VirTechBio, NuvOx, & Pharma

Posted on by yun
20
Oct

Dublin, Oct. 20, 2023 (GLOBE NEWSWIRE) — The “Artificial Blood and Plasma: Global Markets to 2027” report has been added to ResearchAndMarkets.com’s offering. The artificial blood market was estimated to be $23.9 million in 2022 and is forecasted to grow at a compound annual growth rate (CAGR) of 9.2% to reach a value of $40.5 […]

Continue reading →
Congenital disorders

Cytogenetic Systems Industry is forecasted to secure a value of US$ 5,327.8 Million by 2032

Posted on by yun
20
Oct

Global Cytogenetic systems industry demand is anticipated to be valued at US$ 1,688.5 Million in 2022, forecast to grow at a CAGR of 11.0% to be valued at US$ 5,327.8 Million from 2022 to 2032. Growth is attributed to the increase in incidence of genetic disorders and cancer. The major techniques of cytogenetic testing include fluorescence in-situ hybridization, multiplex-fluorescence in situ hybridization, comparative […]

Continue reading →
Blood

Blood thinners could be the answer to controlling feral hog population, study finds

Posted on by yun
19
Oct

FORT BEND COUNTY, Texas (KTRK) — A medication found in many people’s medicine cabinets is being used to control the wild hog population. Blood thinners could be the answer to rooting out the nocturnal creature. Missouri City and Sugar Land are no strangers to being swarmed by packs of wild hogs as urban sprawl moves […]

Continue reading →